Reactivation of latent tuberculosis with TNF inhibitors: critical role of the beta 2 chain of the IL-12 receptor
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Reactivation of latent tuberculosis with TNF inhibitors: critical role of the beta 2 chain of the IL-12 receptor
Authors
Keywords
-
Journal
Cellular & Molecular Immunology
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-05-21
DOI
10.1038/s41423-021-00694-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Local and systemic effects of IL-17 in joint inflammation: a historical perspective from discovery to targeting
- (2021) Pierre Miossec Cellular & Molecular Immunology
- Incidence of tuberculosis in patients receiving anti-TNF therapy for rheumatic diseases: a systematic review
- (2020) Natália Sarzi Sartori et al. CLINICAL RHEUMATOLOGY
- Risk of tuberculosis reactivation during IL‐17 inhibitor therapy for psoriasis: A systematic review
- (2020) E. Fowler et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- TNF-α antagonists differentially induce TGF-β1-dependent resuscitation of dormant-like Mycobacterium tuberculosis
- (2020) Ainhoa Arbués et al. PLoS Pathogens
- Risk of tuberculosis reactivation with IL‐17 and IL‐23 inhibitors in psoriasis ‐ time for a paradigm change
- (2020) Miguel Nogueira et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Association of Secukinumab Treatment With Tuberculosis Reactivation in Patients With Psoriasis, Psoriatic Arthritis, or Ankylosing Spondylitis
- (2020) Boni E. Elewski et al. JAMA Dermatology
- Tuberculosis
- (2019) Jennifer Furin et al. LANCET
- Molecular, Immunological, and Clinical Features of 16 Iranian Patients with Mendelian Susceptibility to Mycobacterial Disease
- (2019) Shokouh Azam Sarrafzadeh et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Risk Factors for Indeterminate Interferon-Gamma Release Assay for the Diagnosis of Tuberculosis in Children—A Systematic Review and Meta-Analysis
- (2019) Noëmi R. Meier et al. Frontiers in Pediatrics
- Immunological Impacts of Diabetes on the Susceptibility of Mycobacterium tuberculosis
- (2019) Birhanu Ayelign et al. Journal of Immunology Research
- A population-based study of tuberculosis incidence among rheumatic disease patients under anti-TNF treatment
- (2019) Natália Sarzi Sartori et al. PLoS One
- Incipient and Subclinical Tuberculosis: a Clinical Review of Early Stages and Progression of Infection
- (2018) Paul K. Drain et al. CLINICAL MICROBIOLOGY REVIEWS
- Preventive therapy for tuberculosis in rheumatological patients undergoing therapy with biological drugs
- (2018) Delia Goletti et al. Expert Review of Anti-Infective Therapy
- Mendelian susceptibility to mycobacterial disease: 2014-2018 update
- (2018) Jérémie Rosain et al. IMMUNOLOGY AND CELL BIOLOGY
- Selected cytokine pathways in rheumatoid arthritis
- (2017) Mélissa Noack et al. Seminars in Immunopathology
- Active Tuberculosis Incidence and Characteristics in Patients Treated with Tumor Necrosis Factor Antagonists According to Latent Tuberculosis Infection
- (2017) Eun Hye Lee et al. Scientific Reports
- Secukinumab in Active Rheumatoid Arthritis: A Phase III Randomized, Double-Blind, Active Comparator- and Placebo-Controlled Study
- (2017) Francisco J. Blanco et al. Arthritis & Rheumatology
- Risk of infections using anti-TNF agents in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: a systematic review and meta-analysis
- (2016) Silvia Minozzi et al. Expert Opinion On Drug Safety
- Interleukins (from IL-1 to IL-38), interferons, transforming growth factor β, and TNF-α: Receptors, functions, and roles in diseases
- (2016) Mübeccel Akdis et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Tuberculosis
- (2016) Madhukar Pai et al. Nature Reviews Disease Primers
- Guidance for the management of patients with latent tuberculosis infection requiring biologic therapy in rheumatology and dermatology clinical practice
- (2015) Fabrizio Cantini et al. AUTOIMMUNITY REVIEWS
- T cell subsets and their signature cytokines in autoimmune and inflammatory diseases
- (2015) Itay Raphael et al. CYTOKINE
- Infection risk associated with anti-TNF-α agents: a review
- (2015) Giuseppe Murdaca et al. Expert Opinion On Drug Safety
- Inherited and acquired immunodeficiencies underlying tuberculosis in childhood
- (2015) Stéphanie Boisson-Dupuis et al. IMMUNOLOGICAL REVIEWS
- Safety and Efficacy of Open-label Subcutaneous Ixekizumab Treatment for 48 Weeks in a Phase II Study in Biologic-naive and TNF-IR Patients with Rheumatoid Arthritis
- (2015) Mark C. Genovese et al. JOURNAL OF RHEUMATOLOGY
- IL-12 and IL-23 cytokines: from discovery to targeted therapies for immune-mediated inflammatory diseases
- (2015) Michele W L Teng et al. NATURE MEDICINE
- TNF biology, pathogenic mechanisms and emerging therapeutic strategies
- (2015) George D. Kalliolias et al. Nature Reviews Rheumatology
- Latent Mycobacterium tuberculosis Infection
- (2015) Haileyesus Getahun et al. NEW ENGLAND JOURNAL OF MEDICINE
- Gamma Interferon Release Assays for Detection of Mycobacterium tuberculosis Infection
- (2014) M. Pai et al. CLINICAL MICROBIOLOGY REVIEWS
- B Lymphocyte Autoimmunity in Rheumatoid Synovitis Is Independent of Ectopic Lymphoid Neogenesis
- (2014) T. Cantaert et al. JOURNAL OF IMMUNOLOGY
- Mendelian susceptibility to mycobacterial disease: Genetic, immunological, and clinical features of inborn errors of IFN-γ immunity
- (2014) Jacinta Bustamante et al. SEMINARS IN IMMUNOLOGY
- Unexpected Role for IL-17 in Protective Immunity against Hypervirulent Mycobacterium tuberculosis HN878 Infection
- (2014) Radha Gopal et al. PLoS Pathogens
- Innate and adaptive immunity in inflammatory bowel disease
- (2013) Alessandra Geremia et al. AUTOIMMUNITY REVIEWS
- Inherited IL-12p40 Deficiency
- (2013) Carolina Prando et al. MEDICINE
- Patients with the most advanced rheumatoid arthritis remain with Th1 systemic defects after TNF inhibitors treatment despite clinical improvement
- (2013) Agata Kosmaczewska et al. RHEUMATOLOGY INTERNATIONAL
- A phase Ib multiple ascending dose study evaluating safety, pharmacokinetics, and early clinical response of brodalumab, a human anti-IL-17R antibody, in methotrexate-resistant rheumatoid arthritis
- (2013) David A Martin et al. ARTHRITIS RESEARCH & THERAPY
- IFN-γ Release Assays in the Diagnosis of Latent Tuberculosis Infection among Immunocompromised Adults
- (2012) Gil Redelman-Sidi et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Anti-TNF treatment blocks the induction of T cell-dependent humoral responses
- (2012) Gabriela Franco Salinas et al. ANNALS OF THE RHEUMATIC DISEASES
- Role of lymphoid chemokines in the development of functional ectopic lymphoid structures in rheumatic autoimmune diseases
- (2012) Elisa Corsiero et al. IMMUNOLOGY LETTERS
- Risk of developing tuberculosis under anti-TNF treatment despite latent infection screening
- (2012) Aranzazu Jauregui-Amezaga et al. Journal of Crohns & Colitis
- Severe disseminated mycobacterial infection in a boy with a novel mutation leading to IFN-γR2 deficiency
- (2012) Sara Sebnem Kilic et al. JOURNAL OF INFECTION
- Targeting IL-17 and TH17 cells in chronic inflammation
- (2012) Pierre Miossec et al. NATURE REVIEWS DRUG DISCOVERY
- Biphasic emergence of active tuberculosis in rheumatoid arthritis patients receiving TNFα inhibitors: the utility of IFNγ assay
- (2011) Der-Yuan Chen et al. ANNALS OF THE RHEUMATIC DISEASES
- Interferon-γ release assay in the diagnosis of latent tuberculosis infection in arthritis patients treated with tumor necrosis factor antagonists in Korea
- (2011) Boksoon Chang et al. CLINICAL RHEUMATOLOGY
- IL-12Rβ1 Deficiency in Two of Fifty Children with Severe Tuberculosis from Iran, Morocco, and Turkey
- (2011) Stéphanie Boisson-Dupuis et al. PLoS One
- Role of IL-17 in the Th1 systemic defects in rheumatoid arthritis through selective IL-12R 2 inhibition
- (2010) M.-L. Toh et al. ANNALS OF THE RHEUMATIC DISEASES
- IL-17 and Th17 cells in tuberculosis
- (2010) Egídio Torrado et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Revisiting Human IL-12Rβ1 Deficiency
- (2010) Ludovic de Beaucoudrey et al. MEDICINE
- Drug-specific risk of tuberculosis in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the British Society for Rheumatology Biologics Register (BSRBR)
- (2009) W. G. Dixon et al. ANNALS OF THE RHEUMATIC DISEASES
- The relationship between synovial lymphocyte aggregates and the clinical response to infliximab in rheumatoid arthritis: A prospective study
- (2009) Ruth Klaasen et al. ARTHRITIS AND RHEUMATISM
- IL-17 inhibits human Th1 differentiation through IL-12Rβ2 downregulation
- (2009) Myew-Ling Toh et al. CYTOKINE
- Illuminating the Black Box of TNF Action in Tuberculous Granulomas
- (2008) Elizabeth A. Miller et al. IMMUNITY
- Tumor necrosis factor antagonist mechanisms of action: A comprehensive review
- (2007) Daniel Tracey et al. PHARMACOLOGY & THERAPEUTICS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now